课题基金 / 基金详情

Childhood Growth, Biological Aging and Midlife Cardio-Metabolic Outcomes

Childhood Growth, Biological Aging and Midlife Cardio-Metabolic Outcomes
儿童期生长、生物衰老和中年心脏代谢结果
批准号:
9750243
负责人:
WEI CHEN
金额:
$7.57万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2020-04-30

项目摘要

项目成果

WEI CHEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Middle age is a critical period for cardio-metabolic diseases, including coronary artery disease, hypertension and type 2 diabetes. The importance of impact of childhood adverse growth experience on adult cardio-metabolic diseases has long been recognized. Telomere length and DNA methylation (DNAm) age are highly correlated with chronological age and considered as biomarkers of human aging. Recent studies have clarified that changes in telomere length and DNAm predict cardio-metabolic disease, atherosclerosis and mortality. Despite extensive studies on the early origins of cardio-metabolic disease and biological aging, the combined effect of prenatal experience, early life developmental patterns and cardio-metabolic aging process is not well understood and remains an important research area. This secondary data analysis proposal is directed to the following Specific Aims: 1) To examine the impact of early life growth trajectory patterns on telomere age, DNAm age and cardio-metabolic disease in middle-aged black and white adults; 2) To investigate the temporal relationship of BMI-telomere and BMI-DNAm and the effect of their temporal sequence patterns on adult cardio-metabolic disease; 3) To determine the mediation effect of telomere and DNAm aging biomarkers on the association of early life growth and risk burden with adult cardio-metabolic risk; 4) To examine whether race, gender and birth weight modify the association and mediation effect parameters. The cardio-metabolic outcomes include hypertension, type 2 diabetes, coronary artery disease and subclinical cardiovascular measures. Telomere length and DNAm age will be used as mediators. The specific aims will be achieved by leveraging the existing longitudinal cohort of the Bogalusa Heart Study followed from childhood since 1973. We propose to analyze two cohorts: a longitudinal cohort of 3,627 adults (2,285 whites and 1,342 blacks), aged 28-61 years, who have height, body mass index (BMI), skin folds measured 3-9 times in childhood and 2-6 times in adulthood, and a sub-cohort of 1,168 adults (747 whites and 421 blacks) who also have telomere data and genome-wide 450K DNAm profiles measured at two time-points 5-12 years apart in adulthood. Cross-lagged models for temporal relationship analysis, mediation analysis models, regression models and interaction analysis models will be performed. Findings on the impact of early life growth on cardio-metabolic disease in relation to biological aging markers will facilitate identification of high risk individuals and selection of novel therapeutic and intervention strategies in early life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Grainyhead-Like 2 Suppresses Entry Factors of SARS-CoV-2 in Epithelial Cells of Oral Mucosa.
Targeting Grainyhead-Like 2 Suppresses Entry Factors of SARS-CoV-2 in Epithelial Cells of Oral Mucosa.
Protection of donor kidneys with synchronization modulation electric field (SMEF)
  • 批准号:
    10705847
  • 项目类别:
  • 资助金额:
    $80.42万
  • 财政年份:
    2021
  • 负责人:
    WEI CHEN
  • 依托单位:
Protection of donor kidneys with synchronization modulation electric field (SMEF)
  • 批准号:
    10603207
  • 项目类别:
  • 资助金额:
    $80.33万
  • 财政年份:
    2021
  • 负责人:
    WEI CHEN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: